We have examined the localization and numbers of acetylcholine receptors (AChRs) within adult mammalian skeletal muscle using '251-cw-bungarotoxin
show that, in muscles of young adult rats, internal AChRs occur in a number and pattern of distribution similar to that for surface membrane AChRs. Internal AChRs are found only in perijunctional regions of normally innervated muscles, but they appear all along the length of muscle fibers after denervation. A minority of internal AChRs may be newly synthesized AChRs en route to insertion in the surface membrane; however, most internal AChRs appear to be antigentically different from and to behave independently of surface membrane AChRs. With increasing age, internal AChRs decline in number, while surface AChRs remain relatively constant. In older animals, internal AChRs may reappear in muscles that have undergone degeneration and regeneration. We conclude that a significant proportion of AChRs in skeletal muscle may be intracellular.
Internal AChRs are a useful marker for young muscle cells. Their distribution may provide information about the intracellular pathways of AChR metabolism.
Acetylcholine receptors (AChRs) in mammalian skeletal muscle are found both on the surface membrane and within the cell. Numerous studies of surface AChRs have shown that, in normal adult muscle, AChRs are located primarily at neuromuscular junctions (Barnard et al., 1971; Fambrough and Hartzell, 1972; Albuquerque et al., 1974; Fertuck and Salpeter, 1974; Daniels and Vogel, 1975) . After denervation new AChRs appear in the extrajunctional surface membrane (Miledi and Potter, 1960; Hartzell and Fambrough, 1972; Libelius, 1974; Chang et al., 1975; Pestronk et al., 1976) . Studies of internal AChRs in developing or cultured muscle have identified them, in relatively small numbers, along the length of fibers associated with Golgi apparatus and multivesicular bodies (Fambrough and Devreotes, 1978; Atsumi, 1981) . It has been proposed that internal AChRs represent either newly synthesized AChRs, in transport to the surface, or internalized AChRs en route to lysosomal degradation (Fumagalli et al., 1982) . However, there have been few studies of internal AChRs in adult muscle; little is known about their ' This work was supported by Grants 5POl NSlO9020 and 5ROl HD04817 from the National Institutes of Health. I am grateful to D. 8. Drachman for helpful discussions on the manuscript, to M. J. Peper and R. N. Adams for technical assistance, and to C. F. Barlow-Salemi and R. A. White for assistance in the preparation of the manuscript.
distribution or their changes with aging or denervation. Definition of the number and localization of internal AChRs should provide information about the intracellular pathways associated with the patterns of distribution of surface AChRs.
In this study, we have examined internal AChRs in vivo, in normal and denervated adult rat skeletal muscle, and in vitro, in cultured rat skeletal muscle. Internal AChRs were exposed by permeabilizing membranes in paraformaldehyde-fixed muscle using the detergent saponin and were labeled with '251-,-bungarotoxin (a-BuTx). Our results show that, in the muscles of 3-to 7-month old rats, there are large numbers of internal ol-BuTx binding sites with properties similar to AChRs. The distribution of these sites parallels that of surface AChRs in innervated and denervated muscle. After 7 months of age, internal sites decline in number but they recur in regenerated muscle fibers.
Materials and Methods
Most experimental procedures were carried out using female SpragueDawley rats (aged 1 to 18 months). Female Lewis rats (aged 3 to 4 months)
were used in the anti-AChR antibody experiments. AChRs from the electric organ of Torpedo californicus were purified by affinity chromatography (Pestronk et al., 1983) . Anti-AChR antibodies were raised in Lewis rats by immunization with 50 pg of AChR, emulsified in an equal volume of Freund's complete adjuvant, and injected intradermally.
Anti-Torpedo AChR antibody titers averaged 1685 f 218 X 10M9 M at the time soleus muscles were removed for study. a-BuTx (Miami Serpentarium) was repurified by ionexchange chromatography using a Whatman CM-32 column (Lee et al., 1972) .
Muscles were pinned at resting length in dishes containing modified Hams F-12 culture medium, teased longitudinally into thin strips, and incubated for 30 min in a 2% paraformaldehyde fixative solution that preserves CK-BuTx binding to AChRs (Fambrough and Devreotes, 1978) . (The fixative was prepared as follows: paraformaldehyde was dissolved in 20 mM sodium phosphate buffer, pH 7.2 (80 to 85"C), to make a 2% formaldehyde solution. This was allowed to cool, and lysine (as the free base; final concentration, 100 mM) and sucrose (final concentration, 60 mu) were added. The solution was reheated (80°C), and sodium periodate was added (final concentration, 10 mu).) After returning to room temperature, the fixative could be used immediately or kept refrigerated for several days. Before labeling with 'Z51-a-BuTx, muscles were washed twice for 10 min in the culture medium.
Exposure of internal AChRs. To allow a-BuTx access to intracellular AChRs muscle membranes were permeabilized using saponin. Fixed muscle was treated for 6 min with 0.5% saponin in 20 mM sodium phosphate buffer, pH 7.2. Muscles were then washed three times in culture medium over 15 min.
Labeling of AChRs.
To label AChRs with '251-~-BuT~ fresh, fixed, or fixedsaponin treated muscles were: (7) incubated for 3 to 4 hr at 37°C in culture medium containing 0.1 to 0.15 pg/ml '*'I-a-BuTx (specific activity, 2 to 6 X 10" Ci/mol); (2) rinsed 12 times at 5-min intervals with Hanks' balanced salt solution containing 0.5% bovine serum albumin (fraction V) buffered at pH 7.2 with HEPES, 4.3 gm/liter; allowed to stand in a refrigerator at 4'C overnight;
washed 5 more times; and (3) fixed in 2.5 to 5% glutaraldehyde for 30 min to 3 hr to allow subsequent teasing of the muscle fiber bundles. 1977; Drachman et al., 1982) . Muscle cells (5 x 10") were plated per culture dish. They were incubated at 37°C under an atmosphere of 10% carbon dioxrde In "standard medrum" consisting of Eagle's minimum essential medium with Earle's salts, supplemented with 10% horse serum, 10 units/ ml of penicillin, 100 units/ml of streptomycrn, and 2.5 pg/ml of amphotericin B (Fungizone).
The number of AChR sites per culture was determined using '251-a-BuTx binding. Eight to 10 days after plating, the cultures were fixed as above for 30 min. Some were then treated with 0.5% saponin for 5 min and washed twrce. AChRs were saturated with 0.2 pg/ml '251-a-BuTx (specific activity, 2 to 5 x lo4 Ci/mol) at 37°C for 30 min, and the unbound toxin was removed by washing four times with wash medium. The cultures were then extracted with two 1 -ml washings with 2% Triton X-l 00 in phosphate-buffered saline, pH 7.2, to solubilize the '251-a-BuTx-labeled AChRs, and the radioactivity in the extracts was counted. Results are reported as specific counts of '"51-oc-BuTx binding (defined as above) per cluture dish.
immunological comparison of infernal a-BuTx binding sites with surface AChRs. Internal WBUTX binding sites and surface AChRs were extracted from cultured muscle fibers in order to compare their binding to anti-AChR antibody.
Labeled' surface AChRs were prepared by incubatrng unfixed muscle cultures with '251-~-BuT~, washing, and extracting with Triton X-100, all as above. A preparation of labeled internal a-BuTx-binding sites was obtained by (7 ) blocking surface AChRs with 1 .O pg/ml unlabeled a-BuTx at 37°C for 30 mrn; (2) washing and extracting as above; (3) labeling solubilized internal sites by adding a 3 to 1 O-fold excess of '*'I-cu-BuTx; and (4) removing unbound "51-a-BuTx using a Sephadex G-200 column. Duplicate serial dilutions of rat serum containing high titers of anti-rat AChR anitbody were added to aliquots of surface AChRs and internal a-BuTx binding sites, and the mixtures were incubated for 18 hr at 4°C. Antibody-receptor complexes were precipitated by addition of goat anti-rat IgG (Appel et al., 1975; Lindstrom et al., 1976) . The percentage of radioactivity precipitated at each serum dilution was calculated.
Specific antibody binding was then derived by subtractrng the amount of nonspecific receptor precipitation in preparations with similar dilutions of control normal rat serum. Statistical methods.
Results are expressed as mean -t standard error. The significance of the differences between experimental groups was calculated by the Student's two-sample t test.
Results a-Bungarotoxin binding sites in normal young adult rat limb muscles Junctional sites. Innervated 4-month-old rat soleus muscle contained 1.6 + 0.1 x IO7 AChRs/NMJ as measured by '?cu-BuTx binding to fresh muscle. When measured immediately after fixation (see "Materials and Methods"), the number of AChRs/NMJ (1.7 + 0.2 x 107) was not significantly different (Table I) . However, when membranes were permeabilized with saponin immediately before (YBuTx binding, the number of apparent "junctional" AChRs approximately doubled to a total of 3.4 f 0.3 X lo7 sites, an additional 1.7 f 0.3 X lo7 oc-BuTx sites/NMJ. When fixed muscles were allowed to stand at 4'C for 1 week (another method of permeabilizing the membrane), the oc-BuTx binding increased to a similar degree (Table  I) . Permeabilization of the extensor digitorum longus (EDL) muscle membrane also revealed significant additional numbers of a-BuTx binding sites (Table I) . Autoradiography (Figs. 1 and 2) showed that the newly revealed sites were found inside the muscle fibers primarily in perijunctional regions within 200 to 300 pm of the NMJ. There were few internal or surface sites beyond this region (Table II) .
"Extrajunctional" sites. We compared the response of internal extrajunctional sites after denervation with the expected increase of surface extrajunctional AChRs (Table II) . In control muscles, there were only 1.5 f 0.2 X lo3 AChRs/pm of muscle fiber length on the surface membrane and 1.3 + 0.4 X lo3 internal a-BuTx sites/Fm. After denervation surface and internal values rose to 16.2 + 1.5 x lo3 and 16.9 + 2.8 X IO3 sites/pm, respectively on day 4, and to 25.8 + 1.9 X 1 O3 and 22.5 + 2.0 X 1 O3 sites/pm on day 7. Thus, surface and internal sites increased progressively and in parallel after denervation.
Similarity of internal cu-BuTx-binding sites to AChRs
Binding properties. We next compared the abilities of AChR blocking agents to bind to internal ol-BuTx sites and to AChRs on the muscle surface membrane. Initial experiments showed that internal sites, like AChRs, bind ol-BuTx in an irreversible manner. The amount of '251-a-BuTx bound to internal sites was similar whether muscles were washed for 5 hr (1.7 f 0.2 x IO7 sites/NMJ) or 72 hr (1.6 + 0.1 x lo7 AChRs/NMJ). Preincubation with 40 pg/ml of unlabeled ol-BuTx blocked virtually all subsequent surface and internal binding of '251-labeled a-BuTx. Residual binding averaged 0.1 + 0.1 x lo7 sites/NMJ for both internal and surface cu-BuTx binding sites (Table Ill) .
Curare blocked internal and surface binding of mu-BuTx by similar proportions. Because a-BuTx eventually displaces curare, this experiment was carried out at brief times of c~-BuTx binding (% hr). Pretreatment of 7-day denervated soleus muscles for 15 min with 3 pg/ml curare significantly inhibited a-BuTx binding. Curare reduced extrajunctional surface binding of a-BuTx by 76% (p < 0.01) from 7.5 f 1.9 X lo3 to 1.8 + 0.4 X lo3 sites/pm. A similar degree of inhibition (70%) (p < 0.01) was seen on a-BuTx binding to internal sites, reducing a-BuTx binding from 12.6 + 4.8 x lo3 to 3.8 f 1.3 X 1 O3 sites/pm. These results show that AChR-blocking agents had similar effects on internal oc-BuTx binding sites and surface AChRs.
Metabolism. If internal a-BuTx binding sites are precursors of surface AChRs en route to membrane insertion, then inhibition of protein synthesis should reduce internal sites, earlier than it reduces surface AChRs (Patrick et al., 1977; Fambrough and Devreotes 1978) . However, treatment with puromycin reduced surface AChRs and internal mu-BuTx binding sites to a similar degree (Fig. 3) . Fifty microliters of 0.4 mg/ml puromycin were injected into 7-day denervated soleus muscles. After 4 hr extrajunctional surface AChRs and internal sites were reduced to 95 and 93% (24.4 + 4.3 x IO3 and Reduction of surface AChRs by a-BuTx blockade or exposure to antiAChR antibody had no effect on internal a-BuTx binding sites. Soleus muscles of 4-month-old rats were studied.
Internal a-BuTx Experimental Procedure Surface AChRs/NMJ Brndrng Sites/ (X 10') NMJ (X 10')
Control (8) x 22hr figure 3. Effect of puromycin on surface and internal a-BuTx binding sites in 7-day denervated soleus muscle. A single injection into the soleus muscle of 20 pg of puromycin in 50 /II of Ringer's solution produced a moderate decline in both internal and surface sites over a 22.hr period. Data are expressed as mean f SEM.
Four days after blockade surface junctional AChRs had partially recovered to 0.4 f 0.1 X lo', while internal sites were again unchanged at 1.2 f 0.2 x 10' (Table Ill) . In muscles exposed to anti-AChR antibody, there is chronic damage to NMJs and an increased degradation rate of junctional AChRs, resulting in decreased numbers of surface AChRs. We examined soleus muscles from animals with high titers of anti-AChR antibody 5 weeks after immunization with AChR. Surface AChRs were reduced by 60% (p < 0.01) to 0.7 f 0.1 x IO', while internal sites were unchanged at 1.2 + 0.2 x 107. Thus, reducing surface Al-BuTx binding sites by blocking them or by increasing their internalization and degradation had no effect on internal sites.
Aging.
There was a marked change in the relative distribution of surface AChRs and internal sites with aging (Table IV) . In most animals up to 7 months of age, there were significant numbers of internal perijunctional binding sites. At 1 month, there were 0.3 + 0.1 x 10' internal sites per NMJ compared to 0.7 f 0.1 X 1 O7 surface AChRs/NMJ. By 4 months of age, both values had increased to 1.7 f 0.3 x 10' and 1.7 f 0.2 x IO', respectively. Thereafter, surface AChRs/NMJ remained relatively constant, while internal sites declined (Table IV) . A similar dissociation with aging was noted for extrajunctional surface AChRs and internal sites. In 4-month-old animals, surface AChRs and internal sites increased in parallel 7 days after denervation to 25.9 + 1.9 x lo3 and 22.5 f 2.0 x IO3 sites/pm, respectively. In l-year-old animals, surface AChRs increased to similar levels (26.7 f 2.6 x lo3 sites/pm) 7 days after denervation, but a significant increase of internal sites could not be detected (1 .l t-1.2 X 1 O3 sites/pm). Two experiments were carried out to control for the possibility that the reduction of internal c~-BuTx sites was due to reduced membrane permeability in older muscle fibers. Autoradiography of cross-sections of incompletely washed '"51-oc-BuTx-treated specimens showed grains within the muscle fibers. In addition, longer exposure of muscles to a higher concentration of saponin (1% for 12 to 15 min) failed to increase internal LYBuTx binding. This suggests that the reduced internal a-BuTx binding in older muscles is probably not an artifact secondary to poor permeabilization of membranes. Thus, in older animals, surface AChRs are unchanged, while internal LI-BuTx sites are markedly reduced even in denervated muscles actively synthesizing AChRs for insertion into the surface membrane. Histological examination of frozen cross-sections of older muscles revealed no obvious morphological differences from younger ones.
Internal sites in regenerating muscle. This experiment was designed to determine whether internal sites would reappear in older muscles that were damaged and allowed to regenerate. At the beginning of the experiment, surface AChRs and internal perijunctional sites averaged 2.1 + 0.2 X 10' and -0.1 + 0.3 X 10' per NMJ, respectively, in soleus muscles from a group of 1 O-month-old rats (Table IV ). The opposite soleus was then injected with 60 ~1 of 3% Marcaine (bupivacaine HCI, Sterling-Winthrop) solution (producing extensive muscle fiber necrosis). Five months later (a time several months after regeneration was complete, when muscle histology had returned virtually to normal), significant numbers of internal perijunctional sites had reappeared in the soleus, averaging 1.9 + 0.4 x 10' sites/NMJ. Surface AChRs/NMJ in these muscles measured 1.4 f 0.2 X 10'. These results show that internal mu-BuTx sites reappear in the muscles of older animals after fiber damage and regeneration. The number of surface AChRs remained unchanged from 4 to 18 months of age. Internal sites were abundant in younger animals but disappeared with increasing age. These sites reappeared if muscles were damaged and allowed to regenerate. Devreotes, 1978)-33% of surface AChR levels. We therefore examined internal cu-BuTx binding sites in cultured rat skeletal muscle. Our results showed that, as for our in vivo results, internal sites and surface AChRs were present in similar numbers. The difference in the number of internal sites between this and previous studies could be explained by the fact that muscle fibers in the present experiments were not exposed to C&JTX until the time of assay. In previous studies, muscle fibers were grown in the presence of unlabeled a-BuTx. In our experiments, the apparent number of internal sites was reduced by 49% in muscle fibers cultured for 3 to 5 days with unlabeled a-BuTx before assay with "51-a-BuTx.
As with oc-BuTx bindlng in vivo, surface and internal sites in vitro varied in parallel; cultures with high levels of surface AChRs had high internal levels was well (Fig. 4) . Levels of both surface AChRs and internal sites were both increased after addition of tetrodotoxin (1 Om6 M) to cultures for 48 hr (Table V) . However, puromycin (20 fig/ ml) treatment of cultures for 5 hr significantly reduced internal sites by 23%, while surface AChRs fell only 9% (Table V) . This suggests that approximately 14 to 23% of the internal sites in muscle in vitro are similar to the "newly synthesized" AChRs previously demonstrated in other studies.
Immunological comparison of internal a-BuTx binding sites with surface AChRs We used an immunoprecipitation assay to compare the binding of anti-AChR antibody to surface AChRs and internal a-BuTx binding sites (Fig. 5) . At a low relative concentration of anti-AChR antibody, there was a 3-fold difference in the precipitation of internal sites (23%) and surface AChRs (72%). However, this difference narrowed with increasing amounts of antibody. At the highest concentration of antibody, a similar degree of internal sites (82%) and surface AChRs (92%) was precipitated. Thus, although there seemed to be antigenic differences between the two preparations, both surface AChRs and internal a-BuTx binding sites were recognized by antiAChR antibody.
Discussion
Characterization of internal OC-BuTx binding sites. In this study, we have examined cu-BuTx binding sites within adult rat skeletal muscles in viva and compared the results with those from cultured rat skeletal muscle. Internal sites were exposed by permeabilizing the fixed cell membrane with a detergent and were labeled using '251-a-B~Tx. Our data show that internal sites are present in large numbers, both in developing and young adult rat muscle. These internal sites have several properties in common with AChRs on the surface membrane. They are probably analogous to the internal AChRs previously identified in cultured (Patrick et al., 1977; Fambrough and Devreotes, 1978) and developing muscle (Atsumi, 1981) , although we have found that they occur in significantly larger numbers. The sites are not an artifact of exposure to saponin, since permeabilizing the membrane by 1 to 7-day storage of the fixed muscle, without detergent, reveals similar numbers of internal sites.
The internal cu-BuTx binding sites in skeletal muscle are probably AChRs. (The ability of a cell to bind a-BuTx does not prove it Figure 5 . Comparison of immunopreciprtation of surface AChRs and internal a-BuTx binding sites. At high concentrations, anti-AChR antibody recognized both molecules which suggests that both are AChRs. However, at lower concentrations of antibody more surface than internal receptors were precipitated, which suggests that there are antigenic differences between them. In each assay, 50 ~1 of diluted serum were added to 250 ~1 of the '?cY-BuTx-receptor preparation. Serum dilutions ranged from 1:200 to undiluted. Results were expressed as the percentage of '251-~-BuTx-labeled receptor precipitated. At each serum concentration, surface AChR and internal site data were calculated by subtracting nonspecific counts precipitated in the presence of normal rat s&urn from counts precipitated by antr-AChR antibody. Each data mint represents the me& of two assays.
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Vol . 5, No. 5, May 1985 ___-0 ---___ , 1975; Brown and Fumagalli, 1977; Patrick and Stallcup, 1977; Carbonetto et al., 1978; Ravdin et al., 1981; Jacob and Berg, 1983) ). The results of our study support the idea that internal sites are AChRs. In young muscle, surface AChRs and internal sites have a similar distribution. Both are present at or near the NMJ in normal muscle and appear in extrajunctional regions after denervation. The binding of a-BuTx to internal sites is specific and saturable. Preexposure of internal sites to unlabeled cu-BuTx completely inhibits subsequent binding of 1*51-~-BuTx. Anti-AChR antibody recognizes the internal a-BuTx binding sites. Further evidence that internal sites are AChRs is provided by the curare blocking data. Preexposure of internal sites and surface AChRs to curare blocks binding of a-BuTx to both, to the same degree. Finally, other studies have shown by a variety of techniques that intracellular a-BuTx binding sites in skeletal muscle seem similar to cell surface AChRs (Devreotes et al., 1977; Patrick et al., 1977) . a-BuTx binding sites that are detergent-extracted from skeletal muscle show single peaks for junctional and extrajunctional sites on zone sedimentation and isoelectric focusing (Brockes and Hall, 1975) . The internal AChRs are not simply newly exposed sites on existing surface AChRs. The antibody binding studies suggest that there are antigenic differences between the two. In addition, autoradiography of muscles shows that surface and internal AChRs have a different distribution, In innervated muscle, surface AChRs are located at the NMJ, in a small area 20 to 50 pm in length, while internal AChRs are also found in perijunctional regions within 200 to 300 Frn of the NMJ. Cross-sections of muscle show that the internal AChRs are distributed within muscle fibers, while exposed AChRs are located only at the surface.
Relationship between internal and surface AChRs. Previous studies have found that the number of internal AChRs in skeletal muscle was about 20 to 33% that of surface AChRs (Fambrough and Devreotes, 1978) . They suggested that many of these AChRs were newly synthesized and being transported, over a period of 3 hr, to the cell surface, where they are endocytosed and degraded, with a half-life of about 20 to 30 hr. It has also been shown that some internal AChRs are former surface AChRs, endocytosed and apparently en route to lysosomal degradation (Fumagalli et al., 1982) . There is no evidence for internal recycling of endocytosed AChRs back into the surface membrane.
It appears from our data that the majority of the internal AChRs in rat skeletal muscle are not newly synthesized precursors of surface AChRs. If most internal AChRs were presursors of surface molecules, then one would predict that a reduction in internal AChRs [ANTI-AChR ANTIBODYJ would be followed by a similar change on the surface. In fact, the loss of internal AChRs with aging occurs without a significant reduction of surface AChRs. In addition, there may be as many internal AChRs as surface ones, far more than the 10 to 15% of surface AChRs that could be explained simply by a 3-hr supply of newly synthesized AChRs. In vitro studies show that inhibition of protein synthesis reduces "newly synthesized" internal AChRs by 80 to 90% within 3 hr (Devreotes and Fambrough, 1975; Patrick et al., 1977) . In contrast, our results show that a 5-hr inhibition of protein synthesis has only a small effect on the total number of internal AChRs. Our culture results suggest that newly synthesized AChRs comprise about 14 to 23% of the internal pool. This figure may be considerably lower at the neuromuscular junction in viva, where AChRs may have a significantly longer average half-life. It also seems unlikely that most of the internal AChRs result from endocytosis of surface AChRs. Blockade of surface AChRs with aBuTx does not reduce internal AChRs after either several hours or days are allowed for equilibration. Similarly, there is no change in internalAChRs when surface AChRs are reduced by an antibodyinduced acceleration of their endocytosis.
Conclusions. It seems likely that the internal a-BuTx binding sites demonstrated in this study are AChRs. This large population of internal molecules (AChRs) usually associated with the surface membrane seems similar to the internal sodium channels found in frog myocardial dytosol (Doyle et al., 1982) . The function of such internal receptors remains unclear; however, they could represent some form of oversynthesis of AChRs that becomes more precisely regulated in later life. If so; it suggests that the muscle cell possesses a postsynthetic mechanism that controls the number of AChRs inserted into the cell membrane. Eventually, however, AChR synthesis itself seems to become more precisely regulated, as reflected by the disappearance of most internal AChRs after 6 to 8 months. This change provides an interesting 'intracellular analogy to the loss of "supernumerary" cells or cell processes during the development of the nervous system (Cowen et al., 1984) .
Our results show that motor nerves can induce localization not only of surface AChRs to the NMJ but also of internal AChRs to perijunctional regions. This could reflect localized perijunctional synthesis of AChRs within innervated muscle fibers or intracellular transport to the NMJ of AChRs synthesized all along the muscle cell. In either case, it will be interesting to define the mechanisms by which the small surface neuromuscular contact controls the organization of molecules within a considerably larger intracellular space.
The place of internal AChRs in the overall metabolic pathway of AChRs is still undefined. It is possible that they are not inserted into the surface membrane because of some difference in their structure.
